Effect of Dry Sudation and Amritadi Churna in Rheumatoid Arthritis

A Comparative study to evaluate the effect of Ruksha Sweda and Amritadi Churna in the management Of Amavata w.s.r to Rheumatoid Arthritis - Ruamvat

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043315

Enrollment

Registered

2022-06-16

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients are selected irrespective of sex, occupation , caste etc. 2. The patients between ages of 20 to 60 years are included in the study. 3. Patients with classical signs and symptoms of Amavata will be taken for study

Exclusion criteria

Exclusion criteria: 1. Subjects associated with any systemic chronic illness such as Diabetes , Hypertension , Heart disease and Renal disease. 2. Patients who leave the treatment in between . 3. Patients with cervical or Ankylosing spondylosis or S.L.E. 4. Patients with anatomical deformities. 5. Patients with chronicity >6yrs. 6. Patients with pregnancy. 7. Patients of age group 60 yrs. 8. Patients who lies in the criteria of Swedana Karma Ayogya.

Design outcomes

Primary

Measure	Time frame
Relief in pain and stiffness of affected jointsTimepoint: 40 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Garima

Govt. P.G. Ayurveda College and Hospital Varanasi, Uttar Pradesh , 221001, India

manish.arnav@gmail.com9415896482

Outcome results